A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

Clinical trial NCT07628049 · RECRUITING

Trial details

NCT number: NCT07628049
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections+Metapneumovirus

Start date: 2026-06-05
Primary completion: 2029-04-05
Enrollment: 1808

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.